The therapeutic effect of vascular endothelial growth factor gene- or heme oxygenase-1 gene-modified endothelial progenitor cells on neovascularization of rat hindlimb ischemia model

Journal of Vascular Surgery

Volumn 58, Issue 3, 2013, Pages

  Wang, Shenming ^a   Long, Jianting ^a   Wang, Sanming ^b   Zhang, Yuanqi ^a   Liu, Xiangxia ^a   Zhang, Hui ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HEME OXYGENASE 1; VASCULOTROPIN A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; BLOOD FLOW; BONE MARROW; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIAL PROGENITOR CELL; GENE; GENETIC TRANSFECTION; HEME OXYGENASE 1 GENE; LEG ISCHEMIA; LIMB SALVAGE; LIMBAL STEM CELL TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; VASCULAR ENDOTHELIAL GROWTH FACTOR GENE;

EID: 84883190994     PISSN: 07415214     EISSN: 10976809     Source Type: Journal    
DOI: 10.1016/j.jvs.2012.11.096     Document Type: Article

References (35)

1. A.T. Hirsch, Z.J. Haskal, N.R. Hertzer, C.W. Bakal, M.A. Creager, and J.L. Halperin ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease), endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation, National Heart, Lung, and Blood Institute: Society for Vascular Nursing, TransAtlantic Inter-Society Consensus, and Vascular Disease Foundation Circulation 113 2006 e463 e654
2. D.J. Collinson, and R. Donnelly Therapeutic angiogenesis in peripheral arterial disease: can biotechnology produce an effective collateral circulation? Eur J Vasc Endovasc Surg 28 2004 9 23
3. M.D. Iafrati, J.W. Hallett, G. Geils, G. Pearl, A. Lumsden, and E. Peden Early results and lessons learned from a multicenter, randomized, double-blind trial of bone marrow aspirate concentrate in critical limb ischemia J Vasc Surg 54 2011 1650 1658
4. R.J. Powell, W.A. Marston, S.A. Berceli, R. Guzman, T.D. Henry, and A.T. Longcore Cellular therapy with Ixmyelocel-T to treat critical limb ischemia: the randomized, double-blind, placebo-controlled RESTORE-CLI trial Mol Ther 20 2012 1280 1286
5. M.P. Murphy, J.H. Lawson, B.M. Rapp, M.C. Dalsing, J. Klein, and M.G. Wilson Autologous bone marrow mononuclear cell therapy is safe and promotes amputation-free survival in patients with critical limb ischemia J Vasc Surg 53 2011 1565 1574.e1
6. F. Timmermans, J. Plum, M.C. Yöder, D.A. Ingram, B. Vandekerckhove, and J. Case Endothelial progenitor cells: identity defined? J Cell Mol Med 13 2009 87 102
7. C.H. Chiang, P.H. Huang, F.P. Chung, Z.Y. Chen, H.B. Leu, C.C. Huang, and T.C. Wu Decreased circulating endothelial progenitor cell levels and function in patients with nonalcoholic fatty liver disease PLoS One 7 2012 e31799
8. G. Giannotti, C. Doerries, P.S. Mocharla, M.F. Mueller, F.H. Bahlmann, and T. Horvàth Impaired endothelial repair capacity of early endothelial progenitor cells in prehypertension: relation to endothelial dysfunction Hypertension 55 2010 1389 1397
9. C. Urbich, and S. Dimmeler Endothelial progenitor cells: characterization and role in vascular biology Circ Res 95 2004 343 353
10. A.J. Devanesan, K.A. Laughlan, H.R. Girn, and S. Homer-Vanniasinkam Endothelial progenitor cells as a therapeutic option in peripheral arterial disease Eur J Vasc Endovasc Surg 38 2009 475 481
11. D.W. Losordo, and J.M. Isner Vascular endothelial growth factor-induced angiogenesis: crouching tiger or hidden dragon? J Am Coll Cardiol 37 2001 2131 2135
12. G.A. Pantely, and J.M. Porter Therapeutic angiogenesis: time for the next phase J Am Coll Cardiol 36 2000 1245 1247
13. J. Dulak, J. Deshane, A. Józkowicz, and A. Agarwal Heme oxygenase-1 and carbon monoxide in vascular pathobiology: focus on angiogenesis Circulation 117 2008 231 241
14. A. Grochot-Przeczek, J. Dulak, and A. Jozkowicz Haem oxygenase-1: non-canonical roles in physiology and pathology Clin Sci (Lond) 122 2012 93 103
15. A. Loboda, A. Jazwa, A. Grochot-Przeczek, A.J. Rutkowski, J. Cisowski, and A. Agarwal Heme oxygenase-1 and the vascular bed: from molecular mechanisms to therapeutic opportunities Antioxid Redox Signal 10 2008 1767 1812
16. B. Bussolati, and J.C. Mason Dual role of VEGF-induced heme-oxygenase-1 in angiogenesis Antioxid Redox Signal 8 2006 1153 1163
17. A. Grochot-Przeczek, J. Dulak, and A. Jozkowicz Heme oxygenase-1 in neovascularisation: a diabetic perspective Thromb Haemost 104 2010 424 431
18. J.X. Yu, X.F. Huang, W.M. Lv, C.S. Ye, X.Z. Peng, and H. Zhang Combination of stromal derived factor-1 alpha and vascular endothelial growth factor gene-modified endothelial progenitor cells is more effective for ischemic neovascularization J Vasc Surg 50 2009 608 616
19. T. Asahara, T. Takahashi, H. Masuda, C. Kalka, D. Chen, H. Iwaguro, and Y. Inai VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells EMBO J 18 1999 3964 3972
20. C. Muscari, C. Gamberini, I. Basile, F. Bonafé, S. Valgimigli, and O. Capitani Comparison between culture conditions improving growth and differentiation of blood and bone marrow cells committed to the endothelial cell lineage Biol Proced Online 12 2010 90 106
21. S. Maeda, I. Nakatsuka, Y. Hayashi, H. Higuchi, M. Shimada, and T. Miyawaki Heme oxygenase-1 induction in the brain during lipopolysaccharide- induced acute inflammation Neuropsychiatr Dis Treat 4 2008 663 667
22. L.A. Wiley, B.A. Berkowitz, and J.J. Steinle Superior cervical ganglionectomy induces changes in growth factor expression in the rat retina Invest Ophthalmol Vis Sci 47 2006 439 443
23. E. Karathanasis, L. Chan, L. Karumbaiah, K. McNeeley, C.J. D'Orsi, and A.V. Annapragada Tumor vascular permeability to a nanoprobe correlates to tumor-specific expression levels of angiogenic markers PLoS One 4 2009 e5843
24. P.Y. Muller, H. Janovjak, A.R. Miserez, and Z. Dobbie Processing of gene expression data generated by quantitative real-time RT-PCR Biotechniques 32 2002 1372 1374 1376, 1378-9
25. Y. Yao, Z. Sheng, Y. Li, F. Yan, C. Fu, and Y. Li Tissue kallikrein promotes cardiac neovascularization by enhancing endothelial progenitor cell functional capacity Hum Gene Ther 23 2012 859 870
26. S.V. Rajkumar, T. Leong, P.C. Roche, R. Fonseca, A. Dispenzieri, and M.Q. Lacy Prognostic value of bone marrow angiogenesis in multiple myeloma Clin Cancer Res 6 2000 3111 3116
27. V.J. Dzau, M. Gnecchi, A.S. Pachori, F. Morello, and L.G. Melo Therapeutic potential of endothelial progenitor cells in cardiovascular disease Hypertension 46 2005 7 18
28. N. Ferrara, K. Carver-Moore, H. Chen, M. Dowd, L. Lu, and K.S. O'Shea Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene Nature 380 1996 439 442
29. H.A. Kim, S. Lim, H.H. Moon, S.W. Kim, K.C. Hwang, and M. Lee Hypoxia-inducible vascular endothelial growth factor gene therapy using the oxygen-dependent degradation domain in myocardial ischemia Pharm Res 27 2010 2075 2084
30. K. Yamamizu, K. Kawasaki, S. Katayama, T. Watabe, and J.K. Yamashita Enhancement of vascular progenitor potential by protein kinase A through dual induction of Flk-1 and Neuropilin-1 Blood 114 2009 3707 3716
31. A. Jazwa, J. Stepniewski, M. Zamykal, J. Jagodzinska, M. Meloni, and C. Emanueli Pre-emptive hypoxia-regulated HO-1 gene therapy improves post-ischemic limb perfusion and tissue regeneration in mice Cardiovasc Res 97 2013 115 124
32. A.C. Teng, D. Kuraitis, S.A. Deeke, A. Ahmadi, S.G. Dugan, and B.L. Cheng IRF2BP2 is a skeletal and cardiac muscle-enriched ischemia-inducible activator of VEGFA expression FASEB J 24 2010 4825 4834
33. S. Masoumi Moghaddam, A. Amini, D.L. Morris, and M.H. Pourgholami Significance of vascular endothelial growth factor in growth and peritoneal dissemination of ovarian cancer Cancer Metastasis Rev 31 2012 143 162
34. K.H. Chan, M.K. Ng, and R. Stocker Heme oxygenase-1 and cardiovascular disease: mechanisms and therapeutic potential Clin Sci (Lond) 120 2011 493 504
35. C.W. Lee, E. Stabile, T. Kinnaird, M. Shou, J.M. Devaney, and S.E. Epstein Temporal patterns of gene expression after acute hindlimb ischemia in mice: insights into the genomic program for collateral vessel development J Am Coll Cardiol 43 2004 474 482